Synopsys, Inc.
NASDAQSynopsys has surged 22% in a single week to $505.17, its strongest weekly move in recent memory, and the question now is whether positioning and analyst targets have adjusted fast enough to reflect where the stock actually is. The analyst community has been moving in the right direction, though the pace of revisions still leaves the consensus price target at $570.57, roughly 13%…
SNPS upgraded to Buy by HSBC with $700 price target, implying 65% upside from $425 current price; analyst raised from Hold.
Synopsys has surged 22% in a single week to $505.17, its strongest weekly move in recent memory, and the question now is whether positioning and analyst targets have adjusted fast enough to reflect where the stock…
Synopsys reported its Q4 results on September 30 and the stock closed down 0.6% to $415.09, a muted reaction that leaves the bullish setup from the past two weeks largely intact but still unconfirmed by price. The…
Snapshot as of 10 Oct 2026
Synopsys arrives at its September 30 earnings report on the back of a 10.6% weekly rally and the clearest bullish analyst consensus the stock has seen in years. The options market captures the shift most vividly. The…
Three distinct signals converged on SNPS Wednesday. An analyst upgrade, a sharp shift in options positioning, and a cost-to-borrow move arrived within 24 hours — each pointing in broadly the same direction. BNP Paribas…
SNPS heads into its September 30 earnings date with two bellwether upgrades in hand, short sellers quietly adding to positions, and a stock trading well below where the Street thinks it belongs. The most newsworthy…
Synopsys jumped 13.4% on August 27 to $464.89. The earnings beat triggered a wave of bullish repositioning across multiple data sets simultaneously. Why this matters: Three distinct signals — analyst upgrades, options…
Synopsys delivered its earnings after the bell on August 26, and the immediate market reaction has shifted the week's story: the stock jumped 3.6% on Tuesday to $408.79, short sellers cut positions sharply, and the gap…
Synopsys reports after the bell on August 26 with a notable divergence: short sellers are stepping back even as the stock sits roughly 30% below where analysts think it should trade. The lending market tells a clear…
Synopsys heads into its August 26 earnings release with analysts pulling targets lower, the stock trading well below consensus price objectives, and last quarter's painful double-digit drop still fresh in institutional…
Synopsys heads into the back half of 2026 with a quiet but persistent buildup in short positions, even as the Street remains broadly constructive and the borrow market shows no sign of stress. The most striking feature…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SNPS — free to start on ORTEX.
Sign up for free →Open SNPS on ORTEX